Katherine A., Hughes

Katherine A. Hughes serves as a lead representative within the Division of Acquisition Policy, where she plays a pivotal role in shaping federal procurement standards, policy guidance, and acquisition best practices. Her work directly informs the development and implementation of contracting frameworks used across government agencies, ensuring alignment with statutory requirements, regulatory compliance, and efficient acquisition outcomes. She specializes in the design and refinement of solicitation templates, contract clauses, and evaluation methodologies—particularly for pharmaceutical and medical supply chains. While she does not award contracts directly, her policy directives influence how acquisition professionals across the federal government structure and execute procurements, making her a key enabler of standardized, transparent, and compliant purchasing practices. Katherine does not maintain direct contractor relationships, as her role is policy-focused rather than operational. She collaborates with agency contracting officers, legal advisors, and procurement analysts to ensure policy consistency and regulatory integrity. Her influence extends to industry stakeholders through guidance documents, interagency working groups, and training initiatives that clarify expectations for vendors participating in federal procurement. She fosters a collaborative environment grounded in clarity, fairness, and adherence to the Federal Acquisition Regulation. Her procurement approach reflects a strict preference for non-set-aside acquisitions, with 100% of her policy guidance supporting full and open competition. This reflects a strategic emphasis on maximizing market participation, minimizing barriers to entry, and ensuring that procurement decisions are driven by technical merit and value rather than socioeconomic categorization. Katherine’s primary industry focus is NAICS 424210—Drugs and Druggists’ Sundries Merchant Wholesalers—indicating deep expertise in pharmaceutical distribution, medical supply chain logistics, and bulk procurement of prescription and over-the-counter medications. She specializes in the acquisition of pharmaceutical products, medical devices, and related healthcare commodities, ensuring that federal supply chains are resilient, compliant with FDA and DEA regulations, and aligned with public health priorities. Her technical domain expertise centers on the unique regulatory and logistical demands of procuring controlled substances and high-volume medical inventory.